Skip to Content

CPHI Middle East 2026

The leading global hub for the pharmaceutical industry in the heart of the Middle East

Starts
Asia/Baghdad
Ends
Asia/Baghdad
Add to calendar:

CPHI Middle East: The Heart of Pharma Innovation

Time period:
  • From May 11 to May 13, 2026.
City / State:
  • Riyadh / Kingdom of Saudi Arabia.
Location:
  • Riyadh Exhibition & Convention Center - Malham.
Areas of Interest:
  • The complete pharmaceutical supply chain: a comprehensive coverage that starts from raw materials and active pharmaceutical ingredients (APIs) to the final pharmaceutical products.
  • Manufacturing and Technologies: Focusing on the latest advanced machines and equipment for drug production, as well as smart and innovative packaging solutions.
  • Biological and Medical Innovation: A review of the latest advancements in biological solutions and biotechnologies for the production of treatments and vaccines.
  • Contractual and logistical services: This includes laboratory services, contract research (CRO), and contract manufacturing organizations (CDMO), in addition to cold supply chain solutions.
Who should participate?
  • Manufacturers and suppliers: Global and local pharmaceutical manufacturing companies, and suppliers of chemical and natural ingredients and raw materials.
  • Innovators and researchers: specialists in the research and development (R&D) sector who seek to showcase patents or modern therapeutic technologies.
  • Investors and decision-makers: those seeking investment opportunities in the growing Saudi healthcare sector, and senior executives in the procurement sector.
  • Regulatory and governmental bodies: Representatives from the Ministry of Health and regulatory authorities to ensure compliance with international standards and open direct communication channels.
Expected number of participants / Attendance notes:
  • More than 60,000 visitors are expected, with over 1,000 exhibiting brands from 110 countries participating; the event is held under the auspices of the Saudi Ministry of Health in collaboration with the "Alliance" Company.
Reasons for Importance:
  • A gateway to the largest regional market: it provides direct access to the Saudi pharmaceutical market, the largest in the region, which is expected to reach a size of $15 billion by 2028.
  • Support for localizing industry: It actively contributes to achieving the goals of "Vision 2030" for localizing the pharmaceutical industry and reducing reliance on imports by building international strategic partnerships.
  • A platform for contracting and building relationships: It is the largest professional gathering that allows for large commercial deals and connects global suppliers with local manufacturers under one roof.
  • Knowledge Exchange and Leadership: Hosting conferences and panel discussions led by global experts to discuss future challenges and opportunities in the pharmaceutical industry.

Submit Application